The FDA now accepts RWE for device submissions without needing identifiable patient data, facilitating the use of large, de-identified databases. This change addresses previous limitations that ...
Companies can ask the FDA to waive premarket authorization and investigational device requirements while they collect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback